|
Zeda Fran Rosenberg, Sc.D., microbiologist, epidemiologist and widely recognized expert in HIV biology and prevention, serves as the chief executive officer of the International Partnership for Microbicides (IPM). IPM was founded by Dr. Rosenberg in 2002 and is a nonprofit organization dedicated to developing microbicides and other innovative HIV prevention products and making them available for women in developing countries. Dr. Rosenberg received her undergraduate degree (BA) in biology and mathematics from Douglass College, Rutgers University, and both her master’s degree (SM) in epidemiology and her doctoral degree (ScD) in microbiology from the Harvard School of Public Health. Dr. Rosenberg is widely regarded as a steadfast champion for developing new HIV prevention products, women’s empowerment and protecting women’s health. Her opinions and commentary have been featured in a variety of international media, including New York Times, The Globe and Mail (Canada), The Daily Nation (Kenya), Nature News and the South African Medical Journal.〔http://www.samj.org.za/index.php/samj/article/viewFile/3685/2475〕 She has authored many scientific articles and has been a featured speaker at multiple high-level conferences and events, including the IAS Conference on HIV Pathogenesis, Treatment and Prevention, the International AIDS Conference, Women Deliver, and the United Nations General Assembly Special Session on HIV/AIDS. ==Early career history== From 1999 to 2002 Dr. Rosenberg was the scientific director for the HIV Prevention Trials Network (HPTN) at Family Health International (FHI). In that role, she managed scientific and operational coordination of international clinical trials in the prevention of mother-to-child transmission of HIV, sexual transmission and transmission of HIV through intravenous drug use. From 1987 to 1999, Dr. Rosenberg worked in several capacities at the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH). She was senior scientist in the Division of AIDS from 1995 to 1999. In that capacity, she directed HIV prevention clinical trials, providing leadership, planning, implementation, administration and evaluation of a global program of extramural research on the prevention of HIV transmission in adult populations. Dr. Rosenberg also served as the assistant to the director and then assistant director for prevention research at NIAID from 1987 to 1995. In this position, she was responsible for all scientific research areas related to AIDS, functioning as a liaison and facilitating scientific exchange between intramural research laboratories and the office of the director. She also coordinated the NIAID Tuberculosis (TB) Research effort, representing NIH on the Public Health Service Task Force to Combat Multi-Drug Resistant TB and co-chairing the TB Research Subcommittee. In addition, she was responsible for coordinating other Institute disease-prevention activities, including in the areas of HIV and other sexually transmitted diseases. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Zeda Rosenberg」の詳細全文を読む スポンサード リンク
|